Europe

Location
Mentions
1509
Relationships
10
Events
3
Documents
651
Also known as:
European Union Eastern Europe European and Baltic countries Europe (Euro) Europe / Eurozone European frontier Western Europe European Union (EU) Central Europe Central European countries Eastern European nations West Europe European countries Continental Europe Northern Europe European Economic Area central Europe North Europe United Kingdom/Europe northern Europe EU (European Union) Europe (implied by European Commission) Medieval Europe Europe / EMU European Parliament Europe / EU Europe / Old Continent European Monetary Union European city (Middle photo)

Relationship Network

Loading... nodes
Interactive Network: Click nodes or edges to highlight connections and view details with action buttons. Drag nodes to reposition. Node size indicates connection count. Line color shows relationship strength: red (8-10), orange (6-7), yellow (4-5), gray (weak). Use legend and help buttons in the graph for more guidance.

Event Timeline

Interactive Timeline: Hover over events to see details. Events are arranged chronologically and alternate between top and bottom for better visibility.
10 total relationships
Connected Entity Relationship Type
Strength (mentions)
Documents Actions
person Mr. Trump
Political diplomatic strain
6
1
View
location Japan
Geopolitical economic relations
5
1
View
location Japan
Geopolitical and economic relations
5
1
View
person Mr. Trump
Political policy change
5
1
View
location United States
Military alliance strained
5
1
View
location ISRAEL
Business associate
5
1
View
location ISRAEL
Trade
5
1
View
location Japan
Economic and diplomatic relations
5
1
View
person Egyptian reconciliation with Palestinians
Positive view
1
1
View
person Assad
Political opposition advocacy for sanctions
1
1
View
Date Event Type Description Location Actions
N/A N/A Funding shortfall for UNFPA following US withdrawal of funds. Global View
2011-01-01 N/A Arab Uprisings / Arab Spring Middle East View
1618-01-01 N/A Thirty Years War Europe View

HOUSE_OVERSIGHT_025177.jpg

This document is an email thread from January 2017 between David Grosof and Jeffrey Epstein. Grosof wishes Epstein a happy birthday and offers 'intellectual consulting' as a gift, specifically in the areas of open science, biotech ventures, and cybersecurity (warning Epstein to secure his communications 'unlike Podesta'). The thread continues with Grosof responding to a list of Epstein's interests, which include 'deception,' 'money,' and 'signal intelligence,' and discusses neurophysiology and consciousness hacking.

Email thread
2025-11-19

HOUSE_OVERSIGHT_025170.jpg

An email thread from January 2017 where David Grosof sends birthday wishes to Jeffrey Epstein and offers professional assistance in open science, bio-tech, cybersecurity (specifically referencing the Podesta leaks), and PR strategy. Epstein (implied author of the top text) replies with a political commentary questioning how to handle a 'Trump-GOP' emergency scenario or a 'radiological attack.' The document includes a confidentiality footer for 'JEE' and the email address jeevacation@gmail.com.

Email thread
2025-11-19

HOUSE_OVERSIGHT_025155.jpg

This document is page 9 of a 'Brockman, Inc. Frankfurt 2016 Hotlist,' bearing a House Oversight Bates stamp. It details book proposals for agency clients, specifically featuring Hugo Mercier's work on cognitive science (referencing his book 'The Enigma of Reason') and a proposal titled 'Genetic Rescue' by Ryan Phelan with contributions by Stewart Brand. The document outlines the academic credentials of the authors and the thematic content of their proposed books, ranging from social psychology to conservation genomics.

Literary agency catalog / book proposal list
2025-11-19

HOUSE_OVERSIGHT_025145.jpg

A single page from a House Oversight document production (Bates stamp 025145) containing a discussion on evolutionary genetics, disease resistance, and human migration. The text analyzes the 'Serial founder effect,' the genetic impact of interbreeding with Neanderthals and Denisovans, and the historical vulnerability of Amerindians to smallpox.

Correspondence / scientific discussion note (likely part of an email chain or attachment)
2025-11-19

HOUSE_OVERSIGHT_025080.jpg

This document appears to be a trip report or background briefing included in House Oversight records. It details a meeting between an unnamed group and Bashar Masri, the CEO of Massar International, at the Rawabi construction site. The text outlines Masri's business ventures, the financing of the Rawabi project (jointly with Qatar Diar), and his reputation as being independent of the Palestinian Authority's inner circle.

Trip report / briefing document (house oversight exhibit)
2025-11-19

HOUSE_OVERSIGHT_025068.jpg

This document, bearing a House Oversight stamp, appears to be a page from a policy report or legislative brief discussing the European Union's stance on Hezbollah. It details the history of sanctions and designations by the Netherlands and the EU between 2002 and 2008, arguing against distinguishing between Hezbollah's political and military wings. While part of a dataset often associated with investigations, this specific page contains no direct mention of Jeffrey Epstein, Ghislaine Maxwell, or their flight logs.

Report / policy brief
2025-11-19

HOUSE_OVERSIGHT_025067.jpg

This document details the command structure of Hezbollah's military and terrorist activities, noting that they report to the Jihad Council, formerly led by Mughniyeh. It explains the secrecy surrounding these operations, which are distinct from the political wing, and discusses how European governments, particularly Britain, have handled the designation of Hezbollah's various wings.

Government report excerpt
2025-11-19

HOUSE_OVERSIGHT_025060.jpg

This page appears to be a page from a briefing document or news summary (marked with House Oversight Bates stamp 025060). The text includes an excerpt discussing the Syrian Civil War, specifically the fragmentation of the FSA and a recommendation to create elite forces to secure chemical weapons. The bottom of the page lists 'Article 5,' a piece from Foreign Policy magazine by Matthew Levitt titled 'Why Does Europe Pretend Hezbollah Has a Good Side?'

News summary / briefing document / congressional oversight record
2025-11-19

HOUSE_OVERSIGHT_025034.jpg

This document appears to be a page from an interview transcript, likely from FrontPage Magazine, featuring an interviewee named Siegel. The text discusses the 'Control Factor' in the context of Islamic extremism, specifically analyzing the Fort Hood shooter Nidal Hasan and the Muslim Brotherhood's strategies in America. The document bears a 'HOUSE_OVERSIGHT' stamp, suggesting it was part of a larger production of documents to the House Oversight Committee, though it contains no direct mentions of Jeffrey Epstein or his known associates on this specific page.

Interview transcript / article excerpt
2025-11-19

HOUSE_OVERSIGHT_024981.jpg

The text discusses the historical challenges and requirements for being a successful Secretary of State, citing past figures like Kissinger and Acheson. It specifically analyzes Hillary Clinton's relationship with President Obama, noting the professional respect but lack of deep personal connection compared to historical examples like Bush and Baker.

Book or report page
2025-11-19

HOUSE_OVERSIGHT_024943.jpg

This document appears to be a page from a House Oversight Committee record (likely related to foreign relations or lobbying) containing a transcript of an interview between 'Al-Sharq al-Awsat Daily' and a high-ranking UAE/Dubai official. The discussion focuses on the UAE's economic resilience during the global financial crisis (likely circa 2008-2009), refuting rumors that Dubai has become a 'ghost city' and highlighting the success of state entities like Emirates Airlines and DP World. While part of a larger document set potentially related to investigations, this specific page contains no direct references to Jeffrey Epstein.

Interview transcript / house oversight committee record
2025-11-19

HOUSE_OVERSIGHT_024910.jpg

This document is page 94 of a Cowen Collaborative Insights research report dated February 25, 2019. It analyzes the industrial hemp market, detailing historical usage (specifically during WWII), current use cases (textiles, biofuels, food), and 2017 import statistics. While the document bears a 'HOUSE_OVERSIGHT' Bates stamp, indicating it was part of a larger congressional investigation (possibly related to Epstein's financial records or subpoenas), the content of this specific page is strictly agricultural and economic market research with no direct mention of Jeffrey Epstein.

Investment research report / market analysis
2025-11-19

HOUSE_OVERSIGHT_024900.jpg

This document is page 84 of a Cowen Collaborative Insights market research report dated February 25, 2019. It details the legal and business landscape of the medical cannabis industry in Chile and Colombia, listing various companies involved such as Dayacann, Tilray, and Canopy Growth. The document bears a 'HOUSE_OVERSIGHT' Bates stamp, suggesting it was gathered as part of a congressional investigation, likely related to financial records or investment bank communications.

Investment research report / market analysis
2025-11-19

HOUSE_OVERSIGHT_024899.jpg

This page from a Cowen market research report, dated February 25, 2019, analyzes the regulatory environment and market trends for CBD and hemp products in Switzerland and France. It details Swiss regulations regarding cosmetic products and recent corporate consolidations (LGC Capital, Wayland, Creso Pharma), while noting France's status as a leading hemp cultivator despite strict government crackdowns on retail CBD sales. The document bears a House Oversight Committee stamp, suggesting it was part of a congressional document production.

Market research report / financial analysis
2025-11-19

HOUSE_OVERSIGHT_024898.jpg

This document is page 82 of a Cowen Collaborative Insights report dated February 25, 2019, analyzing the cannabis and hemp markets in Italy and Switzerland. It details regulatory environments, specifically the 'cannabis light' market in Italy and medical/tobacco substitute regulations in Switzerland, while listing various corporate investments and acquisitions (Wayland, Canopy, CROP). The document bears a 'HOUSE_OVERSIGHT_024898' Bates stamp, indicating it was part of a document production to the House Oversight Committee, likely included in a larger batch of financial records.

Financial research report / market analysis
2025-11-19

HOUSE_OVERSIGHT_024897.jpg

This document is page 81 of a Cowen Collaborative Insights market research report dated February 25, 2019, discussing the regulatory landscape for medical cannabis and CBD in Europe, specifically the UK and Italy. It details the legalization history, licensing requirements involving agencies like the MHRA and FSA, and market activities of companies like GW Pharmaceuticals, Tilray, Bedrocan, Canopy, and Aurora. The document bears a 'HOUSE_OVERSIGHT_024897' Bates stamp, indicating it was part of a document production for a House Oversight Committee investigation.

Market research report / financial analysis
2025-11-19

HOUSE_OVERSIGHT_024896.jpg

This document is page 80 of a financial research report produced by Cowen, dated February 25, 2019, analyzing the regulatory landscape for medical cannabis and CBD in Europe. It details the European Parliament's non-binding resolution to harmonize cannabis policies, compares THC limits between the EU (0.2%) and North America (0.3%), and discusses the classification of CBD within the 'Novel Food Catalogue.' The document bears a 'HOUSE_OVERSIGHT' Bates stamp, indicating it was part of a document production for a congressional investigation.

Financial research report / industry analysis
2025-11-19

HOUSE_OVERSIGHT_024873.jpg

This document is page 57 of a Cowen Collaborative Insights report dated February 25, 2019, detailing the strategies of major Canadian cannabis companies (Aphria, Aurora, Canopy Growth, Cronos, Emblem, and Emerald Health) regarding the hemp and CBD markets. It aggregates quotes from CEO earnings calls and press releases concerning market expansion into Europe and the US, as well as strategic partnerships. The document bears a 'HOUSE_OVERSIGHT' Bates stamp, indicating it was likely part of a document production for a congressional investigation.

Financial research report / industry commentary
2025-11-19

HOUSE_OVERSIGHT_024822.jpg

This document is the Table of Contents for a 'Cowen Collaborative Insights' research report dated February 25, 2019, focusing on the CBD and Cannabis market. The report covers various sectors including consumer products, healthcare, and global landscapes, with sections attributed to specific analysts (e.g., Azer, Nadeau, Schenkel). The document bears a 'HOUSE_OVERSIGHT_024822' Bates stamp, indicating it is part of a document production to the House Oversight Committee, likely related to investigations into financial records.

Financial research report (table of contents)
2025-11-19

HOUSE_OVERSIGHT_024821.jpg

This Cowen report page discusses the global regulatory landscape for CBD, highlighting developments in Europe and Latin America, and analyzes the U.S. regulatory outlook following the 2018 Farm Bill. It details the shifting oversight from the DEA to the Department of Agriculture while noting continued FDA authority and regulatory uncertainty regarding CBD products.

Market research report / financial analysis
2025-11-19

HOUSE_OVERSIGHT_024737.jpg

This page from an Ackrell Capital report discusses the global outlook for cannabis regulation, identifying 2018 as a critical year due to recreational legalization efforts in Canada and California. It argues that the future stance of the U.S. federal government regarding enforcement or legalization will be the single most impactful factor on the global industry's trajectory.

Report excerpt / investment research page
2025-11-19

HOUSE_OVERSIGHT_024735.jpg

This document is page 99 of a 2017 market research report by Ackrell Capital regarding global cannabis regulation. It details the legal status and legislative progress of medical cannabis in New Zealand and various European countries, including Italy, Croatia, Germany, Poland, the Netherlands, and Spain. The document bears a 'HOUSE_OVERSIGHT_024735' stamp, indicating it was part of a document production for a congressional investigation.

Investment research report / market analysis (page 99)
2025-11-19

HOUSE_OVERSIGHT_024729.jpg

This document is page 93 of a 2017 report by Ackrell Capital regarding global cannabis regulation. It discusses international partnerships, banking challenges related to anti-money laundering laws (specifically focusing on U.S. and Uruguayan banking conflicts), and outlines United Nations conventions from 1961 and 1971 regarding narcotic and psychotropic substances. The document bears a 'HOUSE_OVERSIGHT' Bates stamp, indicating it was part of a document production for a congressional investigation.

Investment research report / market analysis (chapter v)
2025-11-19

HOUSE_OVERSIGHT_024221.jpg

This document is Appendix 1 of a 'Global Utility White Paper' produced by Electron Capital Partners, LLC. It details the firm's investment team, led by Portfolio Manager Jos Shaver (formerly of SAC Capital), their global research process, and a 7-year performance track record. The document is explicitly marked 'For exclusive of Jeffrey Epstein' in the footer, indicating he was being pitched as an investor or was an existing client receiving confidential reports.

Investment white paper / pitch deck appendix
2025-11-19

HOUSE_OVERSIGHT_024218.jpg

This document is page 17 of a confidential 'Global Utility White Paper' produced by Electron Capital Partners, LLC, specifically marked for the exclusive use of Jeffrey Epstein. It analyzes historical trends in the utility sector, citing Warren Buffett's investments and market behavior during the dotcom bust, while also drawing parallels to Japan's economic history. The document is part of a larger collection obtained by the House Oversight Committee.

Financial white paper / investment report
2025-11-19
Total Received
$0.00
0 transactions
Total Paid
$0.00
0 transactions
Net Flow
$0.00
0 total transactions
No financial transactions found for this entity. Entity linking may need to be improved.
As Sender
0
As Recipient
0
Total
0
No communications found for this entity. Entity linking may need to be improved.

Discussion 0

Sign in to join the discussion

No comments yet

Be the first to share your thoughts on this epstein entity